<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://peptide.town/story/walgreens-glp-1-coverage-help-pharmacist-calls</loc><news:news><news:publication><news:name>Peptide Town</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-28T16:23:00.000Z</news:publication_date><news:title>Walgreens GLP 1 coverage help adds pharmacist calls and prior authorization support</news:title></news:news></url>
  <url><loc>https://peptide.town/story/employer-glp-1-coverage-shrinks-2027</loc><news:news><news:publication><news:name>Peptide Town</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-28T15:37:00.000Z</news:publication_date><news:title>Employer GLP 1 coverage shrinks as 2027 costs climb</news:title></news:news></url>
  <url><loc>https://peptide.town/story/peptide-syringe-programs-ration-equipment</loc><news:news><news:publication><news:name>Peptide Town</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-28T15:08:00.000Z</news:publication_date><news:title>Peptide syringe programs ration free equipment as peptide users surge</news:title></news:news></url>
  <url><loc>https://peptide.town/story/glp-1-coverage-worries-survey</loc><news:news><news:publication><news:name>Peptide Town</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-27T15:27:00.000Z</news:publication_date><news:title>GLP 1 coverage worries keep half of untreated adults with obesity from starting in a new survey</news:title></news:news></url>
  <url><loc>https://peptide.town/story/glp-1-access-pathways-outside-insurance</loc><news:news><news:publication><news:name>Peptide Town</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-27T14:54:00.000Z</news:publication_date><news:title>GLP 1 access pathways study finds one in three users go outside insurance and regular pharmacies</news:title></news:news></url>
  <url><loc>https://peptide.town/story/type-2-diabetes-quit-glp-1-cost</loc><news:news><news:publication><news:name>Peptide Town</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-27T14:26:00.000Z</news:publication_date><news:title>Cost is the top reason people with type 2 diabetes quit GLP 1 drugs in an Everyday Health survey</news:title></news:news></url>
  <url><loc>https://peptide.town/story/glp-1-misinformation-tiktok-prescribers</loc><news:news><news:publication><news:name>Peptide Town</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-27T13:42:00.000Z</news:publication_date><news:title>GLP 1 misinformation from TikTok keeps three in four prescribers correcting patients every week</news:title></news:news></url>
</urlset>